Dr. MartĂ­n Abadi
Andre Nussenzweig MEMBERS
Head of the Molecular Recombination Unit, National Cancer Institute Center for Cancer Research
United States
More Info
  • 2007
  • Biomedical Engineering (B.M.E.)
More Info
  • 2007
  • Biomedical Engineering (B.M.E.)
Election Remark
Andre Nussenzweig is NIH Distinguished Investigator, Chief of the Laboratory of Genome Integrity (which he established in 2011), National Institutes of Health Distinguished Investigator, and Head of the Molecular Recombination Unit at NIH: National Cancer Institute Center for Cancer Research.
 
He is a leading contributor to the study of mechanisms that maintain genomic stability and prevent cancer. His laboratory has elucidated many fundamental features of DNA damage and repair proteins and revealed the critical role they play in both normal and pathogenic states. Ongoing studies have emphasized the importance of DNA repair pathways as drivers of specific hematological malignancies and as contributors to chemoresistance/sensitivity in breast and ovarian cancers. The goal of his program is to use hypothesis-driven approaches to develop therapeutic strategies in the treatment of cancers.
 
Dr. Nussenzweig received his Ph.D. in Physics from Yale University in 1989. He completed his postdoctoral training in atomic physics in Paris with Dr. Serge Haroche, who was awarded the Nobel prize in Physics in 2012. Subsequently, he became a Research Fellow at Memorial Sloan-Kettering Cancer Center prior to joining the Experimental Immunology Branch as a tenure track investigator in 1998. Dr. Nussenzweig received tenure at NIH in 2003.

He was elected as member of the European Academy of Engineering in 2007.